Patients’ acceptability of a patient-reported outcome measure in cardiac rehabilitation (the PRO-Heart-DK)—a mixed methods study using the Theoretical Framework of Acceptability

被引:0
|
作者
Emma Dedic [1 ]
Heidi Sønderby Vistisen [2 ]
Ann-Dorthe Zwisler [3 ]
Bente Faurby Pedersen [4 ]
Karin Lundsby Kappel [5 ]
Helle Kanstrup [6 ]
Rikke Elmose Mols [4 ]
Cecilie Lindström Egholm [7 ]
机构
[1] Odense University Hospital,REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care
[2] University of Southern Denmark,Department of Clinical Research
[3] Aarhus University Hospital,Department of Cardiology
[4] Odense University Hospital,Department of Cardiology
[5] Rigshospitalet-Copenhagen University Hospital,Rehabilitation and Palliative Care Research Group, Department of Oncology
[6] University of Copenhagen,Department of Clinical Medicine, Faculty of Health and Medical Sciences
[7] Nordfyn Municipality,undefined
关键词
Patient-reported outcome measure; Cardiac rehabilitation; Ischemic heart disease; Acceptability; Theoretical Framework of Acceptability; Patient engagement; Patient management;
D O I
10.1186/s41687-024-00831-8
中图分类号
学科分类号
摘要
Patient-reported outcome measures (PROM) are increasingly applied in clinical settings in order to enhance patient involvement and patient management. The use of PROM in practice is, like any other healthcare intervention, depending on the patients’ accept. Applying survey and interview as methods, this study explored patients’ acceptability of a PROM in cardiac rehabilitation clinical practice using the Theoretical Framework of Acceptability. Overall, the findings indicate that many patients with ischemic heart disease consider PROM to be relevant and useful as part of the cardiac rehabilitation process which suggest high level of acceptability. However, some aspects of the PROM, specifically the perceived questionnaire relevance, comprehensiveness and structure (e.g. lack of suitable response-options) need further improvement to enhance patients’ acceptability and ensure their future engagement.
引用
收藏
相关论文
共 44 条
  • [41] Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot study
    Dempsey, Kathy
    Saw, Robyn
    Bartula, Iris
    Lo, Serigne
    Lawn, Craig
    Pennington, Thomas
    Spillane, Andrew
    Boyle, Frances
    Dong, Skye
    Dieng, Mbathio
    Milne, Donna
    Seaman, Linda
    Saks, Dina
    Lai-Kwon, Julia
    Thompson, Jake Robert
    Morton, Rachael
    BMJ OPEN, 2022, 12 (12):
  • [42] Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy
    Castilla Garcia, Lucia
    Ramos Cillan, Sergio
    Lopez Garcia, Alberto
    Barreras Ruiz, Natalia
    Castillo Bazan, Eva
    Pascual, Adriana
    Riesco Ovelar, Miriam
    Urrutia, Celia
    Cruz, Susana
    Pardo, Alberto
    Herrero, Antonio
    Perez Saenz, Maria Angeles
    Morillo Gilles, Daniel
    Llamas Sillero, Maria Pilar
    Becares, Javier
    Barriocanal, Carla
    Short Apellaniz, Jorge
    del Olmo, Marta
    Arcos Campillo, Javier
    Cordoba, Raul
    BLOOD, 2022, 140 : 5164 - 5166
  • [43] Patient-reported outcome measurement (PROM) program in patients with lymphoma receiving intravenous therapy: Preliminary results of a prospective study using PRO-CTCAE to individualize healthcate and to reduce unscheduled appointments.
    Cordoba, Raul
    Ramos, Sergio
    Castillo, Eva
    Barreras Ruiz, Natalia
    Riesco, Miriam
    Herrero, Antonio
    Cruz, Susana
    Pardo, Alberto
    Pascual, Adriana
    Lopez-Garcia, Alberto
    Perez, Maria-Angeles
    Morillo, Daniel
    Askari, Elham
    Prieto, Elena
    Llamas, Pilar
    Becares, Javier
    Barriocanal, Carla
    del Olmo, Marta
    Short, Jorge
    Arcos, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18670 - E18670
  • [44] Protocol for a mixed-methods study to develop and feasibility test a digital system for the capture of patient-reported outcomes (PROs) in patients receiving chimeric antigen receptor T-cell (CAR-T) therapies (the PRO-CAR-T study)
    Hughes, Sarah E.
    McMullan, Christel
    Aiyegbusi, Olalekan Lee
    Shaw, Karen
    Kinsella, Francesca
    Ferguson, Paul
    Khatsuria, Foram
    Burns, David
    Pyatt, Lester
    Ansell, John
    Chakera, Evelyn
    Richardson-Abraham, Julie
    Denniston, Alastair K.
    Davies, Elin Haf
    Craddock, Charles
    Calvert, Melanie
    BMJ OPEN, 2024, 14 (03):